PNC Financial Services Group’s Dianthus Therapeutics DNTH Stock Holding History

PNC Financial Services Group’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.14M	Buy	37,360 +139	+0.4%	+$8.05K	﹤0.01%	852
2025 Q4	$1.53M	Hold	37,221	–	–	﹤0.01%	1077
2025 Q3	$1.46M	Buy	37,221 +121	+0.3%	+$3.09K	﹤0.01%	1080
2025 Q2	$691K	Hold	37,100	–	–	﹤0.01%	1349
2025 Q1	$673K	Hold	37,100	–	–	﹤0.01%	1344
2024 Q4	$809K	Hold	37,100	–	–	﹤0.01%	1259
2024 Q3	$1.02M	Hold	37,100	–	–	﹤0.01%	1162
2024 Q2	$960K	Hold	37,100	–	–	﹤0.01%	1154
2024 Q1	$1.11M	Buy	+37,100	New	+$806K	﹤0.01%	1114

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PNC Financial Services Group's DNTH Position: Q1 2026 in Review

PNC Financial Services Group increased its Dianthus Therapeutics (DNTH) stake by 0.37% in Q1 2026, buying an estimated $8.05K and bringing the position to 37,360 shares worth $3.14M. The position accounts for ﹤0.01% of the portfolio, ranked #852.

PNC Financial Services Group first reported a position in DNTH in Q1 2024 and has held it in 9 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

PNC Financial Services Group held 37,360 shares of Dianthus Therapeutics worth $3.14M as of Q1 2026.
PNC Financial Services Group bought 139 Dianthus Therapeutics shares in Q1 2026, an estimated $8.05K.
Dianthus Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #852 holding.
PNC Financial Services Group first reported a position in Dianthus Therapeutics in Q1 2024 and has held it in 9 quarters since.
241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.